Dietary methyl donor depletion protects against intestinal tumorigenesis in ApcMin/+ mice

Cancer Prevention Research

Volumn 5, Issue 7, 2012, Pages 911-920

  Kadaveru, Krishna ^a   Protiva, Petr ^a,b   Greenspan, Emily J ^a   Kim, Young In ^c   Rosenberg, Daniel W ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CYANOCOBALAMIN; FOLIC ACID; METHIONINE;

AMINO ACID DEFICIENCY; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INCIDENCE; CANCER INHIBITION; CELL CYCLE REGULATION; COLON CARCINOGENESIS; COLON MUCOSA; CONTROLLED STUDY; CYANOCOBALAMIN DEFICIENCY; DIETARY INTAKE; FOLIC ACID BLOOD LEVEL; FOLIC ACID DEFICIENCY; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INTRACELLULAR SIGNALING; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME; TUMOR VOLUME; WEIGHT GAIN; WEIGHT REDUCTION;

ANIMALS; CALORIC RESTRICTION; DIET; FOLIC ACID; FOLIC ACID DEFICIENCY; GENE EXPRESSION PROFILING; GENES, APC; HUMANS; INTESTINAL NEOPLASMS; MICE; MICE, INBRED C57BL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84866451099     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-11-0544     Document Type: Article

References (43)

1. Mason JB. Folate, cancer risk, and the Greek god, Proteus: a tale of two chameleons. Nutr Rev 2009;67:206-12.
2. Ulrich CM, Potter JD. Folate and cancer-timing is everything. JAMA 2007;297:2408-9.
3. Giovannucci E. Epidemiologic studies of folate and colorectal neoplasia: a review. J Nutr 2002;132:2350S-5S. (Pubitemid 34848106)
4. Harnack L, Jacobs DR Jr., Nicodemus K, Lazovich D, Anderson K, Folsom AR. Relationship of folate, vitamin B-6, vitamin B-12, and methionine intake to incidence of colorectal cancers. Nutr Cancer 2002;43:152-8. (Pubitemid 36134089)
5. Sanjoaquin MA, Allen N, Couto E, Roddam AW, Key TJ. Folate intake and colorectal cancer risk: a meta-analytical approach. Int J Cancer 2005;113:825-8. (Pubitemid 40101266)
6. Farber S, Cutler EC, Hawkins JW, Harrison JH, Peirce EC 2nd, Lenz GG. The action of pteroylglutamic conjugates on man. Science 1947;106:619-21.
7. Cole BF, Baron JA, Sandler RS, Haile RW, Ahnen DJ, Bresalier RS, et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 2007;297:2351-9. (Pubitemid 46883748)
8. Ebbing M, Bonaa KH, Nygard O, Arnesen E, Ueland PM, Nordrehaug JE, et al. Cancer incidence and mortality after treatment with folic acid and vitamin B12. JAMA 2009;302:2119-26.
9. Figueiredo JC, Grau MV, Haile RW, Sandler RS, Summers RW, Bresalier RS, et al. Folic acid and risk of prostate cancer: results from a randomized clinical trial. J Natl Cancer Inst 2009;101:432-5.
10. Gibson TM, Weinstein SJ, Pfeiffer RM, Hollenbeck AR, Subar AF, Schatzkin A, et al. Pre-and postfortification intake of folate and risk of colorectal cancer in a large prospective cohort study in the United States. Am J Clin Nutr 2011;94:1053-62.
11. Stevens VL, McCullough ML, Sun J, Jacobs EJ, Campbell PT, Gapstur SM. High levels of folate from supplements and forti fication are not associated with increased risk of colorectal cancer. Gastroenterology 2011;141:98-105, e1.
12. Protiva P, Mason JB, Liu Z, Hopkins ME, Nelson C, Marshall JR, et al. Altered folate availability modifies the molecular environment of the human colorectum: implications for colorectal carcinogenesis. Cancer Prev Res 2011;4:530-43.
13. Duthie SJ, Horgan G, de Roos B, Rucklidge G, Reid M, Duncan G, et al. Blood folate status and expression of proteins involved in immune function, inflammation, and coagulation: biochemical and proteomic changes in the plasma of humans in response to long-term synthetic folic acid supplementation. J Proteome Res 2010;9:1941-50.
14. Ho GY, Xue X, Cushman M, McKeown-Eyssen G, Sandler RS, Ahnen DJ, et al. Antagonistic effects of aspirin and folic acid on inflammation markers and subsequent risk of recurrent colorectal adenomas. J Natl Cancer Inst 2009;101:1650-4.
15. Walzem RL, Clifford AJ. Folate deficiency in rats fed diets containing free amino acids or intact proteins. J Nutr 1988;118:1089-96.
16. Rong N, Selhub J, Goldin BR, Rosenberg IH. Bacterially synthesized folate in rat large intestine is incorporated into host tissue folyl polyglutamates. J Nutr 1991;121:1955-9.
17. Tamura T. Microbiological assay of folate. In: Picciano MF, Stokstad ELR, Gregory JF, editors. Folic acid metabolism in health and disease. New York: Wiley-Liss; 1990. p. 121-37.
18. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci US A 1998;95:14863-8. (Pubitemid 29003722)
19. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005;102:15545-50. (Pubitemid 41528093)
20. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003;34:267-73. (Pubitemid 36792858)
21. Clifford AJ,Wilson DS, Bills ND. Repletion of folate-depleted rats with an amino acid-based diet supplemented with folic acid. J Nutr 1989;119:1956-61. (Pubitemid 20063890)
22. Kim YI, Hayek M, Mason JB, Meydani SN. Severe folate deficiency impairs natural killer cell-mediated cytotoxicity in rats. J Nutr 2002;132:1361-7. (Pubitemid 34606477)
23. Kim YI, Shirwadkar S, Choi SW, Puchyr M, Wang Y, Mason JB. Effects of dietary folate on DNA strand breaks within mutation-prone exons of the p53 gene in rat colon. Gastroenterology 2000;119:151-61. (Pubitemid 30452588)
24. Song J, Medline A, Mason JB, Gallinger S, Kim YI. Effects of dietary folate on intestinal tumorigenesis in the apcMin mouse. Cancer Res 2000;60:5434-40.
25. Hao X, Sun Y, Yang CS, BoseM, Lambert JD, Ju J, et al. Inhibition of intestinal tumorigenesis in Apc(min/+) mice by green tea polyphenols (polyphenon E) and individual catechins. Nutr Cancer 2007;59:62-9. (Pubitemid 47549782)
26. Chae WJ, Bothwell AL. IL-17F deficiency inhibits small intestinal tumorigenesis in Apc(Min/+) mice. Biochem Biophys Res Commun 2011;414:31-6.
27. Tannenbaum A. Effects of varying caloric intake upon tumor incidence and tumor growth. Ann N Y Acad Sci 1947;49:5-18.
28. Kritchevsky D. Caloric restriction and experimental carcinogenesis. Toxicol Sci 1999;52:13-6. (Pubitemid 30017570)
29. Colman RJ, Anderson RM, Johnson SC, Kastman EK, Kosmatka KJ, Beasley TM, et al. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 2009;325:201-4.
30. Mai V, Colbert LH, Berrigan D, Perkins SN, Pfeiffer R, Lavigne JA, et al. Calorie restriction and diet composition modulate spontaneous intestinal tumorigenesis in Apc(Min) mice through different mechanisms. Cancer Res 2003;63:1752-5. (Pubitemid 36460832)
31. Steinbach G, Heymsfield S, Olansen NE, Tighe A, Holt PR. Effect of caloric restriction on colonic proliferation in obese persons: implications for colon cancer prevention. Cancer Res 1994;54:1194-7. (Pubitemid 24108056)
32. Tannenbaum A, Silverstone H. The influence of the degree of caloric restriction on the formation of skin tumors and hepatomas in mice. Cancer Res 1949;9:724-7.
33. Cheney KE, Liu RK, Smith GS, Meredith PJ, Mickey MR, Walford RL. The effect of dietary restriction of varying duration on survival, tumor patterns, immune function, and body temperature in B10C3F1 female mice. J Gerontol 1983;38:420-30. (Pubitemid 13079090)
34. Klurfeld DM, Welch CB, Davis MJ, Kritchevsky D. Determination of degree of energy restriction necessary to reduce DMBA-induced mammary tumorigenesis in rats during the promotion phase. J Nutr 1989;119:286-91. (Pubitemid 19080840)
35. Song J, Sohn KJ, Medline A, Ash C, Gallinger S, Kim YI. Chemopreventive effects of dietary folate on intestinal polyps in Apc+/-Msh2-/-mice. Cancer Res 2000;60:3191-9. (Pubitemid 30407916)
36. Lindzon GM, Medline A, Sohn KJ, Depeint F, Croxford R, Kim YI. Effect of folic acid supplementation on the progression of colorectal aberrant crypt foci. Carcinogenesis 2009;30:1536-43.
37. Mattar MC, Lough D, Pishvaian MJ, Charabaty A. Current management of in flammatory bowel disease and colorectal cancer. Gastrointest Cancer Res 2011;4:53-61.
38. Barbour KW, Davis T, White A, Baumann H, Berger FG. Haptoglobin, inflammation, and tumorigenesis in the MIN mouse. Redox Rep 2001;6:366-8. (Pubitemid 34134328)
39. Murphy EA, Davis JM, McClellan JL, Gordon BT, Carmichael MD. Curcumin's effect on intestinal infl ammation and tumorigenesis in the ApcMin/+mouse. J Interferon Cytokine Res 2011;31:219-26.
40. Nakanishi M, Montrose DC, Clark P, Nambiar PR, Belinsky GS, Claffey KP, et al. Genetic deletion of mPGES-1 suppresses intestinal tumorigenesis. Cancer Res 2008;68:3251-9.
41. Fischer SM, Hawk ET, Lubet RA. Coxibs and other nonsteroidal antiinflammatory drugs in animal models of cancer chemoprevention. Cancer Prev Res 2011;4:1728-35.
42. Allison MC, Howatson AG, Torrance CJ, Lee FD, Russell RI. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N Engl J Med 1992;327:749-54.
43. Montrose DC, Kadaveru K, Ilsley JN, Root SH, Rajan TV, Ramesh M, et al. cPLA2 is protective against COX inhibitor-induced intestinal damage. Toxicol Sci 2010;117:122-32.